| 1 |
Fu J, Li J, Sun Y, Liu S, Song F, Liu Z. In-depth investigation of the mechanisms of Schisandra chinensis polysaccharide mitigating Alzheimer's disease rat via gut microbiota and feces metabolomics. Int J Biol Macromol 2023;232:123488. [PMID: 36731694 DOI: 10.1016/j.ijbiomac.2023.123488] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Hassan AS, Morsy NM, Aboulthana WM, Ragab A. Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with molecular modeling simulations. RSC Adv 2023;13:9281-303. [PMID: 36950709 DOI: 10.1039/d3ra00297g] [Reference Citation Analysis]
|
| 3 |
Waiker DK, Verma A, Saraf P, T A G, Krishnamurthy S, Chaurasia RN, Shrivastava SK. Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer's Disease. ACS Omega 2023;8:9394-414. [PMID: 36936338 DOI: 10.1021/acsomega.2c08061] [Reference Citation Analysis]
|
| 4 |
Hassan AS, Morsy NM, Aboulthana WM, Ragab A. In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: Design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulation. Drug Dev Res 2023;84:3-24. [PMID: 36380556 DOI: 10.1002/ddr.22008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Punyakoti P, Behl T, Sehgal A, Yadav S, Sachdeva M, Anwer MK, Vargas-De-La-Cruz C, Venkatachalam T, Naqvi M, Verma R, Tuli HS. Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease. Cell Signal 2023;102:110539. [PMID: 36455831 DOI: 10.1016/j.cellsig.2022.110539] [Reference Citation Analysis]
|
| 6 |
Kola A, Lamponi S, Currò F, Valensin D. A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity. Int J Mol Sci 2023;24. [PMID: 36768823 DOI: 10.3390/ijms24032500] [Reference Citation Analysis]
|
| 7 |
Okumura H, Kawasaki T, Nakamura K. Probing protein misfolding and dissociation with an infrared free-electron laser. Methods Enzymol 2023;679:65-96. [PMID: 36682873 DOI: 10.1016/bs.mie.2022.08.047] [Reference Citation Analysis]
|
| 8 |
Rasheed A, Zaheer AB, Munawwar A, Sarfraz Z, Sarfraz A, Robles-Velasco K, Cherrez-Ojeda I. The Allosteric Antagonist of the Sigma-2 Receptors-Elayta (CT1812) as a Therapeutic Candidate for Mild to Moderate Alzheimer's Disease: A Scoping Systematic Review. Life (Basel) 2022;13. [PMID: 36675950 DOI: 10.3390/life13010001] [Reference Citation Analysis]
|
| 9 |
Akhtar A, Gupta SM, Dwivedi S, Kumar D, Shaikh MF, Negi A. Preclinical Models for Alzheimer's Disease: Past, Present, and Future Approaches. ACS Omega 2022;7:47504-17. [PMID: 36591205 DOI: 10.1021/acsomega.2c05609] [Reference Citation Analysis]
|
| 10 |
Nejabati HR, Roshangar L. Kaempferol as a potential neuroprotector in Alzheimer's disease. J Food Biochem 2022;46:e14375. [PMID: 35929364 DOI: 10.1111/jfbc.14375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Van Manh N, Hoang V, Ngo VT, Kang S, Jeong JJ, Ha H, Kim H, Kim Y, Ann J, Lee J. Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents. European Journal of Medicinal Chemistry 2022;244:114837. [DOI: 10.1016/j.ejmech.2022.114837] [Reference Citation Analysis]
|
